The Federal Trade Commission is reopening a 200-year-old debate over the effectiveness of a particular kind of alternative medicine, with a workshop planned for next month that will focus on advertisements...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: